| | | SFA 12wk |
---|
| ↓ | |
---|
| LF 20wk | SFA 20wk | LF + At 8wk | SFA + At 8wk | LF + Pr 8wk | SFA + Pr 8wk | LF + Ib 8wk | SFA + Ib 8wk |
---|
Cholesterol (mM)
| 1.64 ± 0.14 | 1.43 ± 0.08 | 1.17 ± 0.11a | 1.55 ± 0.14 | 1.52 ± 0.17 | 1.37 ± 0.09 | 1.81 ± 0.26 | 1.19 ± 0.11a |
Triglycerides (mM)
| 0.80 ± 0.12 | 0.55 ± 0.14 | 0.40 ± 0.04a | 0.63 ± 0.09 | 0.89 ± 0.09b | 1.00 ± 0.17b | 0.57 ± 0.07 | 0.80 ± 0.14 |
NEFA (mEq/L)
| 0.70 ± 0.04 | 0.61 ± 0.07 | 0.50 ± 0.07a | 0.62 ± 0.05 | 0.62 ± 0.06 | 0.51 ± 0.04a | 0.52 ± 0.04a | 0.52 ± 0.06a |
- The table shows the effects of various feeding regimens on plasma lipids. Plasma total cholesterol, triglycerides and non-esterified fatty acids (NEFA) were measured at the end of the feeding regimen. Data represented as mean ± standard error of mean. Means were compared with non-parametric independent t test, where P < 0.05 considered statistically significant.
- a: statistically significant in comparison to LF.
- b: statistically significant in comparison to SFA.
- Abbreviations: LF, low-fat; SFA, saturated fatty acids; At, atorvastatin; Pr, pravastatin; Ib, ibuprofen; wk, weeks.